Human CCL7/MCP-3/MARC Antibody, R&D Systems™

CCL7/MCP-3/MARC

Western Blot 1 ug/mL, Neutralization 1.5-4.5 ug/mL, Intracellular Staining by Flow Cytometry 2.5 ug/10^6 cells, CyTOF-ready, ELISA Capture (Matched Antibody Pair) 2-8 ug/mL

Monoclonal

Purified

RUO

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

C-C motif chemokine 7, chemokine (C-C motif) ligand 7, FIC, MARC, MCP-3, MCP3Monocyte chemotactic protein 3, MCP-3Small-inducible cytokine A7, MGC138465, Monocyte chemoattractant protein 3, NC28SCYA6, SCYA7MGC138463, small inducible cytokine A7 (monocyte chemotactic protein 3)

CCL7

IgG1

Protein A or G purified from ascites

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

36320

Western Blot, Neutralization, Flow Cytometry, CyTOF, ELISA

Unconjugated

Mouse

Human

Q7Z7Q8

6354

E. coli-derived recombinant human CCL7/MCP-3/MARC Gln34-109 Accession # Q7Z7Q8

Primary

Reconstitute at 0.5 mg/mL in sterile PBS.

Detects human CCL7/MCP-3/MARC in ELISAs and Western blots. In ELISAs, no cross-reactivity with recombinant human (rh) CCL2/MCP-1, rhCCL8/MCP-2, or rhCCL13/MCP-4 is observed.